Pharma To Challenge Legality Of ‘Unfair’ EU Wastewater Directive

The estimated costs to the pharmaceutical and cosmetics industry of introducing a fourth level of urban wastewater treatment are unclear, with the European Commission’s estimate of €1.2bn in dispute.

Pharma argues that more industries should be responsible for covering the cost of additional wastewater treatment. (Shutterstock)
Key Takeaways
  • EFPIA, the industry group representing the pharmaceutical industry, is challenging the legality of the updated Urban Wastewater Treatment Directive, which will make the pharmaceutical and cosmetics industries responsible for covering the cost of upgrading or building new urban water treatment facilities.

The European Federation Of Pharmaceutical Industries and Associations is aiming to challenge the legality of the revised Urban Wastewater Treatment...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Compliance